Delivery Order SPE2DB20D3101-SPE2DB25FRSL2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,154.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-competitive delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, was awarded under firm fixed pricing terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a $1,748.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will fulfill this delivery...
- The Defense Logistics Agency awarded a $7,488.45 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for the diabetes medication, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,436.37 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 4, 2025, with completion scheduled for August 5, 2025. This contract employs firm fixed pricing and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $2,702.70 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed-price, non-set-aside contract is scheduled for completion by August 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,406.58 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract was awarded on a firm fixed-price basis without a set-aside designation, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,546.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by June 26, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,857.57 for Trulicity 0.75 mg/0.5 mL pens, a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSL2Delivery Order
The Defense Logistics Agency awarded a $4,902.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL doses), a diabetes medication. The contract, which carries no set-aside designation, was competitively awarded and is scheduled for completion by August 14, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order. As a child contract under a larger vehicle, this award represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This delivery order falls under AmerisourceBergen Drug Corp's substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The company, a major pharmaceutical distributor headquartered in Pennsylvania, supplies an extensive portfolio of medications and medical supplies to support military healthcare programs and other federal health systems. The IDC enables flexible fulfillment of critical pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/13/25 |